Transplant tourism following the declaration of Istanbul: Poor outcomes and nephrologist dilemma von AlBugami, Meteb M, AlOtaibe, Fahad E, Alabadi, Abdulnaser M, Hamawi, Khaled, Bel'eed‐Akkari, Khalid

Volltext

Impact of COVID-19 pandemic on transplant laboratories: How to mitigate? von Al Attas, Rabab Ali, AlDhafir, Raha, Mohammed, Amani, AlAbduladheem, Dalal, Awaji, Mohammad, AlAjlan, Kenana, AlOtaibi, Ahmed, Bamrdouf, Rafah, Alabadi, Abdulnaser

Volltext

OR13 C3D as a non-invasive tool for early prediction of Antibody Mediated Rejection (AMR) and renal allograft failure von Mostafa, Ahmed, Sidahmed, Abubaker M., Ghandorah, Salim, Yilmaz, Serdar, Tibbles, Lee Anne, Alabadi, Abdulnaser, Wang, Jinguo, Abootaleb, Rahmanian, Khan, Faisal, Berka, Noureddine

Volltext

LBP35: STRENGTH OF DE NOVO HLA DONOR SPECIFIC ANTIBODY IS A STRONG PREDICTOR OR ITS C1Q BINDING CAPABILITY von Ghandorah, Salim, Wang, Jinguo, Ahadzadeh, Amir, Alabadi, Abdulnaser, Yilmaz, Serdar, Khan, Faisal, Berka, Noureddine

Volltext

LBP35 von Ghandorah, Salim, Wang, Jinguo, Ahadzadeh, Amir, Alabadi, Abdulnaser, Yilmaz, Serdar, Khan, Faisal, Berka, Noureddine

Volltext

The dilemma of DQ HLA-antibodies von Al Attas, Rabab, Al Abduladheem, Dalal, Shawhatti, Adel A, Lopez, Ricardo, Liacini, Abdelhamid, AlZahrani, Saber, Akkari, Khalid, Hasan, Nasreen, Alabadi, Abdulnaser

Volltext

40-OR von Khan, Faisal M, Tripathi, Gaurav, Alabadi, Abdulnaser, Ravani, Pietro, Yilmaz, Serdar, Berka, Noureddine

Volltext

40-OR: RENAL ALLOGRAFT RECIPIENTS CARRYING HIGH INTERLEUKIN-10 PRODUCING GENOTYPES HAVE BETTER ALLOGRAFT SURVIVAL von Khan, Faisal M., Tripathi, Gaurav, Alabadi, Abdulnaser, Ravani, Pietro, Yilmaz, Serdar, Berka, Noureddine

Volltext

Pitfall in the interpretation of DQ HLA-antibodies von Al-Attas, Rabab, AlAbduladheem, Dalal, Shawhatti, Adel A, Lopez, Ricardo, Liacini, Abdelhamid, AlZahrani, Saber, Akkari, Khalid, Hassan, Nasreen, Alabadi, Abdulnaser

Volltext